ACSM'S Health & Fitness Journal:
DEPARTMENTS: ACSM NewsBriefs
STUDY SHOWS THAT EXERCISE DURING CHEMOTHERAPY MAY IMPROVE BREAST CANCER OUTCOMES
Is it safe to exercise during chemotherapy? Will exercise interfere with a cancer patient’s ability to respond to chemotherapy? A new study published in the September 2014 issue of Medicine & Science in Sports & Exercise® suggests that exercise is not only safe during chemotherapy but it actually may help breast cancer patients live longer. In the first randomized controlled trial to address this question, Canadian researchers recruited 242 breast cancer patients between 2003 and 2005 and randomized them to receive no exercise (n = 82), aerobic exercise (n = 78), or resistance exercise (n = 82) during their chemotherapy. The researchers then followed up with the patients in 2012 to determine their rates of breast cancer recurrence, death from breast cancer, and death from any cause. Using survival analysis, the study reported that the 8-year disease-free survival was 83% for the two exercise groups combined compared with 76% for the control group. Moreover, the 8-year overall survival was 91% in the exercise groups compared with 83% in the control group. The authors noted that the magnitude of these effects are in line with those reported from chemotherapy agents. The potential mechanisms of such an effect are unknown but may include interactions with cytotoxic chemotherapy through influences on drug distribution, pharmacodynamics, and metabolism (i.e., exercise may act as a “chemosensitizer”). The authors caution that the effects were not statistically significant and that the trial was not designed to answer the question. Nevertheless, the authors note that these preliminary phase II data provide further support for a definitive phase III trial on this question.
MARK YOUR CALENDAR NOW FOR ACSM’S HEALTH & FITNESS SUMMIT & EXPOSITION IN 2015
Before you know it, it will be time again for ACSM’s Health & Fitness Summit & Exposition. Mark your calendars now for March 31 through April 3, 2015, for THE fitness conference for ACSM-certified professionals. The 2015 Summit will be held at the Hyatt Regency Phoenix and Phoenix Convention Center in Phoenix, AZ. Stay tuned to www.acsmsummit.org for more details.
APPLY FOR THE LAWRENCE A. GOLDING SCHOLARSHIP
The Lawrence A. Golding Scholarship is being offered for the tenth consecutive year. The scholarship is designed to publicly recognize undergraduate students who are in their sophomore, junior, or senior year who have made significant outstanding contributions to their communities in the areas of health, fitness, and/or education.
ACSM and Healthy Learning™ underwrites this scholarship, granting two $1,000 awards. The recipients also receive complimentary registration to ACSM’s 2015 Health & Fitness Summit & Exposition to be held March 31 through April 3, 2015, in Phoenix, AZ. Visit www.acsmsummit.org to apply this fall.
GET READY: WORLDWIDE FITNESS TRENDS SURVEY RESULTS ARE COMING!
The ninth annual worldwide survey results will be released in the November/December 2014 issue of ACSM’s Health & Fitness Journal®. See which health and fitness trends will be ranked in the top 20 for 2015 and read expert commentary on the results. The winners of the prize drawing also will be announced.
FREE APP AVAILABLE FROM THE NATIONAL YOUTH SPORTS HEALTH & SAFETY INSTITUTE
The National Youth Sports Health & Safety Institute (NYSHSI) recently launched an app (NYSHSI Healthy Youth Sports) designed to educate and creatively engage youth and adults who are interested in youth sports, health, and safety. The app provides important information, allows users to exchange groundbreaking ideas and best practices, and encourages global networking opportunities with youth sports stakeholders (parents, athletes, coaches, administrators, sports governing bodies, clubs/organizations, and industry). The NYSHSI Healthy Youth Sports app is available as a free download through the App Store (iPhone®/iPad®) and Google Play (Android).
© 2014 American College of Sports Medicine.